evolved recently from an enzootic VEE virus in northern South America. These results suggest continued emergence of epizootic VEE viruses; surveillance of enzootic viruses and routine vaccination of equines should therefore be resumed.
Venezuelan equine encephalitis (VEE) viruses are mosquitoborne alphaviruses (Togaviridae) that cause acute illness in equines and humans, with symptoms ranging from a mild, flu-like syndrome to encephalitis or death. VEE viruses occur throughout the Americas (except Canada) in two distinct transmission cycles: (i) enzootic, in discrete, stable, sylvatic foci, involving primarily rodents and causing little disease in equines and only sporadic human outbreaks, and (ii) epidemic/epizootic, transient cycles in a wide range of ecological settings, involving many different vertebrates with high morbidity and mortality rates in equines and humans (1) . A number of antigenically distinct VEE virus variants, classified into subtypes and varieties, have been identified. However, only variants belonging to subtype I, varieties AB and C, have been associated with epidemics/epizootics (1, 2) . These IAB and IC epizootic, equine-virulent viruses are genetically similar to enzootic, equine-avirulent, variety ID viruses that occur in northern South America and Panama (3, 4) .
Since the 1930s (5) , major epidemics/epizootics of VEE have occurred from the United States to Argentina, involving up to hundreds of thousands of equines and tens of thousands of humans (6, 7) . The largest reported outbreak occurred in Central America from 1969-1972 and eventually spread northward to involve Mexico and the South-Central United States (1, 6). The last report of epizootic VEE virus activity occurred in 1973 on the Guajira Peninsula in Venezuela (8) , prompting speculation that epizootic VEE viruses became extinct (1). However, retrospective phylogenetic analyses indicated that epizootic variety IC viruses evolved on multiple occasions from ID enzootic progenitors and may emerge again (9) .
During the period December 9, 1992-January 28, 1993, the Ministry of Agriculture of Venezuela reported 26 cases (including 10 deaths) of equine encephalitis from 12 sites in the state of Trujillo (east of Lake Maracaibo). Blood samples were taken from apparently healthy equines in contact with these sick animals; of 66 equines sampled, 28 (42%) had antibodies
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to VEE virus. This immunity indicated previous, natural infection because these animals had not been vaccinated against VEE virus. Antibodies were detected by hemagglutination-inhibition (HI) and/or complement fixation (CF) tests (10) ; HI titers ranged from 1:40 to >1:320, while CF titers were from 1:16 to 1:64. Two virus isolates (243797, collected December 18, 1992, and 243884, collected December 28, 1992)
were obtained by intracranial inoculation of suckling mice with serum from two horses that were not ill but had antibodies to VEE virus detectable by HI and CF. These horses were from different municipalities (Pampan and Carache, respectively) and were contacts of others that had been sick or died. Human cases in the area presented with mild, flu-like illness only. Patients attending nearby rural clinics with fevers of unknown origin were tested for serologic evidence of VEE infection, and, of 33 persons sampled during the period of the equine outbreak, 5 (15%) had VEE antibodies. Human virus isolates were obtained by inoculation of Vero cells with serum from patients from Candelaria municipality presenting with intense headache and fever. Isolate SH3 was from the serum of a 41-year-old male, collected on January 9, 1993, 2 days after the onset of disease. Isolate SH5 was from the serum of a 38-year-old male, collected on January 6, 1993, 1 day after disease onset. A small survey of the local population revealed 3 of 20 (15%) persons with serologic evidence of previous VEE virus infection and no illness. Attempts to isolate alphavirus from local mosquitoes were unsuccessful. Although no other VEE cases were reported from this area after January 28, 1993, an equine-vaccination campaign was initiated on February 8, 1993 , with a formalin-inactivated, strain TC-83 vaccine prepared in Venezuela.
In June of 1993, additional cases of equine and human illness were reported in another area of Venezuela (Zulia State, on the western side of Lake Maracaibo). Reports of disease and equine deaths (mainly unvaccinated, feral burros) began in the first week of June in Villa del Rosario Municipality; the number of cases is undetermined because there was no ongoing surveillance in this area. During the period June 7-18, 1993, serum samples were collected from febrile humans in the same area. Of 27 samples, 2 virus isolations were made; both were identified as VEE virus by IFA (indirect immunofluorescent antibody test, using anti-VEE hyperimmune mouse ascitic fluids and goat anti-mouse conjugate). Only one of these, strain 125573, collected from a 16-year-old male 2 days after onset, belonged to subtype I.
Further antigenic and genetic analyses were done on five VEE viruses (three human and two equine) isolated during these two outbreaks. These isolates allowed us to document the emergence of a new epizootic VEE virus in northern South America (after a 20-year hiatus), to determine the probable evolutionary origin of this virus, and to confirm our earlier studies concerning the evolution and generation of epizootic VEE viruses (3, 9) . Viruses used in our analyses are described in Table 1 ; all were passaged twice in BHK-21 cell monolayers for physicochemical purification of virions, RNA isolation, and primerextension sequencing (9) .** An aliquot of the first BHK-21 passage was tested by IFA for confirmation as VEE virus (Table 2 ). Purified virions were tested in an HI assay (10) with rabbit E2 glycoprotein polyclonal antisera (11) and in an ELISA (12) with two monoclonal antibodies (mAbs), for assignment to subtype and variety (13, 14 (14) . Antigenic classification there-**The sequences reported in this paper have been deposited in the GenBank data base (accession nos. L41231-L41243).
fore confirmed that the isolates from this recent outbreak were epizootic, IC-like, in terms of antigenic phenotype.
To determine evolutionary relationships between the 1992-1993 Venezuelan outbreak strains and previously isolated VEE viruses, we used limited-nucleotide sequencing and phylogenetic analyses, which have proven effective in previous studies of VEE (9) and other alphaviruses (16) (17) (18) (19) . The nucleotide sequences of two regions of the RNA genomes of the 5 recent virus isolates were determined and compared with previously published, homologous sequences from other VEE viruses. These sequence regions (rather than the E2 gene, for example) were chosen for comparison because they do not encode antigenic sites that might be subject to immune selection, resulting in rapid change or convergent evolution that might obscure overall evolutionary trends (9) . Sequences from portions of the nsP4 gene, El gene, and 3' untranslated region, totaling 380 nt, were determined (nucleotide numbers 7317-7503 and 11,219-11,413, respectively, of the Trinidad donkey VEE virus sequence; ref. 20) . Four of the isolates from the 1992-1993 epidemic had identical sequences, while isolate SH5 had 2 nt differences in the nsP4 gene, resulting in substitution of Lys-567 by Met and Val-576 by Ile. These sequences were compared with homologous regions from representatives of the entire VEE complex, including multiple variety IAB, IC, and ID strains (9) . Phylogenetic trees were generated by using the PAUP parsimony (21) and the DNAML maximum likelihood (22) programs (Fig. 1) (Fig. 1, PA61) Virus  VEE  EEE  WEE  IAB  IC  ID  IE  IF  II  3B4C-4   1A1B-9   IA  TrD   ND §   ND  ND   32001   800  1600  200  800  200  ND  ND  IC  P676  ND  ND  ND  400  1600  400  <100  400  <100   10,00011   1,000   CoAn5384   ND  ND  ND  1600  800  400  <100  400  <100  10,000  10  ID  3880  ND  ND  ND  400  200  1600  100  800  200  10,000  100,000  83U434  ND  ND  ND  400  400  800  <100  800  <100  10,000  100,000  Unknown  SH3   256011   80  80  400  800  800  <100  200  <100  10,000  1,000  SH5  2560  80  80  400  800  800  <100  400  <100  10,000  10,000  243797  1280  40  40  800  800  400  <100  400  <100  10,000  1,000  243884  1280  40  40  800  800  400  <100  400  <100  10,000  1,000  125573  2560  160  160  800  800  400  <100  400  <100  10, 'Reciprocal endpoint titers (n = 2). sistent results, providing no evidence of recombination within the 26S portion of the genome of any of these isolates. Although recombination within nonstructural regions of the VEE genome or double crossover recombination within the 26S region cannot be ruled out, these possibilities seem remote, considering that recombination has been detected only once (24) in more comprehensive alphavirus phylogenetic studies (17, 18) , as well as detailed analyses of the eastern equine encephalitis (16) , VEE (9) , and western equine encephalitis (S.C.W., unpublished data) complexes.
The apparent discrepancy between the antigenic and genetic analyses of these recent outbreak viruses is due to the close evolutionary link between enzootic and epizootic VEE viruses. Although enzootic and epizootic VEE viruses have historically been considered separate entities, only a few nucleotide changes (<1% of the total genome) separate ID enzootic viruses from epizootic variety IC (3). However, the associated phenotypic changes apparently lead to drastic differences in their epidemiology [spread beyond typical enzootic transmission habitats, production of higher viremias in many mammals, and infection of a wide range of arthropod vectors (1) ].
Ongoing research is directed at understanding the molecular mechanism(s) by which enzootic VEE viruses generate epizootic, virulent strains. Because mutations in both envelope glycoprotein (25) and untranslated genome regions (26) have been implicated in virulence differences among VEE strains, comparisons of complete genomic sequences from recent IC epizootic with ID enzootic isolates will be required to begin evaluation of mutations potentially responsible for virulence changes accompanying epizootic VEE virus emergence. Until an actual progenitor of emerging epizootic viruses has been isolated, even full-length sequences and reverse genetic approaches will not provide definitive answers regarding natural virulence determinants. However, further analysis of isolate SH5, which is antigenically and possibly genetically intermediate between ID and IC viruses, could partially elucidate a step-wise generation of virulent VEE viruses.
Our results underscore the power of phylogenetic sequence analyses in determining the origin of emergent viruses and in predicting new outbreaks. These results and previous retrospective studies (9) 
